<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>It is postulated that <z:e sem="disease" ids="C0020456" disease_type="Disease or Syndrome" abbrv="">hyperglycaemia</z:e> influences the natural history of Type 1 (insulin-dependent) and Type 2 (non-insulin-dependent) <z:hpo ids='HP_0000819'>diabetes mellitus</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain><z:e sem="disease" ids="C0020456" disease_type="Disease or Syndrome" abbrv="">Hyperglycaemia</z:e>, even when mild, can attenuate the secretory response of pancreatic beta and alpha cells to increments in <z:chebi fb="105" ids="17234">glucose</z:chebi> and can impair insulin-mediated <z:chebi fb="105" ids="17234">glucose</z:chebi> transport, thus impeding its own correction and initiating a cycle of progressive self-exacerbation and metabolic deterioration </plain></SENT>
<SENT sid="2" pm="."><plain>Both reduced islet function and insulin action may be the consequence of a generalized down-regulation and/or occupation of <z:chebi fb="105" ids="17234">glucose</z:chebi> transporters by <z:e sem="disease" ids="C0020456" disease_type="Disease or Syndrome" abbrv="">hyperglycaemia</z:e> so that the islets respond less to further increments in glycaemia </plain></SENT>
<SENT sid="3" pm="."><plain>The postulated hyperglycaemic cycle can be initiated by any environmental perturbation that increases insulin demand in previously normoglycaemic patients in whom insulin secretion has already reached a maximum level of compensation for peripheral <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> (as in <z:mp ids='MP_0001261'>obese</z:mp> pre-Type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>) or for a reduced beta-cell mass (as in pre-Type 1 <z:mp ids='MP_0002055'>diabetes</z:mp>) </plain></SENT>
<SENT sid="4" pm="."><plain>Elimination of <z:e sem="disease" ids="C0020456" disease_type="Disease or Syndrome" abbrv="">hyperglycaemia</z:e> by any means can halt this cycle of progressive metabolic deterioration and may restore transiently metabolic recompensation both in Type 1 and Type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="5" pm="."><plain>There is experimental evidence that long-standing severe <z:e sem="disease" ids="C0020456" disease_type="Disease or Syndrome" abbrv="">hyperglycaemia</z:e> may irreversibly damage beta cells </plain></SENT>
</text></document>